Covance Will Soon Be Labcorp Drug Development
We are one global company innovating for millions – together, continuing to bring you more advanced medical breakthroughs.
Articles
The UK officially left the EU on 31 January 2020 entering into the 11-month post-Brexit transition period which itself ends on 31 December 2020. During the transition period the UK continues to follow EU rules and regulations, however what happens at the end of the transition period regarding many things, including regulatory alignment and free trade, is still uncertain. The UK and EU are keen to negotiate a trade deal post transition, but the exact nature of that deal is unclear.
Covance by Labcorp is a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries.
COVANCE is a registered trademark and the marketing name for Covance Inc. and its subsidiaries around the world.
.png){kind=icon}